(MENAFN - America News Hour) Recently, a significant growth in healthcare spending have been observed in the low- and middle-income nations. In the middle-income nations, healthcare spending rose by 6.3% a year between 2000 and 2017, while the economy rose by 5.9% a year. Additionally, health spending in low-income countries also observed a growth by 7.8% a year in the same period. The growth in the healthcare spending of these nations can be attributed to the increasing focus of the governments in these nations to meet the laid down targets of the Sustainable Development Goals (SDGs) of 2030. Such factors are anticipated to drive the growth of the Glioblastoma Market during the forecast period.
Data Bridge Market Research recently added “
Global Hydroxychloroquine Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Global Hydroxychloroquine Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Global Hydroxychloroquine Market, By Strength (200 mg, 400 mg, 800 mg), Indication (Coronavirus disease, Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South Americ
OTC Medications Market 11
OTC medications market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 557.99 billion by 2027 growing at a CAGR of 7.0% in the above-mentioned forecast period. Increasing adoption of OTC drugs will helps in the growth of the market.
The major players covered in the OTC medications market report are Johnson & Johnson Services, Inc., Novartis AG, Bayer AG, sanofi-aventis U.S. LLC, Pfizer Inc., GlaxoSmithKline plc, Perrigo Company plc, Reckitt Benckiser Group plc., Takeda Pharmaceutical Company Limited., Alkem Labs, Sun Pharmaceutical Industries Ltd., Cipla Inc, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd. Piramal Enterprises, Merck & Co., Inc, F. Hoffmann-La Roche Ltd, among other domestic and global players.
Global Antidepressant Drugs Market Size, Status and Forecast 2021-2028
amiFebruary 13, 2021 15
The life of human beings have become highly complex in recent times, and remarks such as life was less complicated years back are often heard. Change in lifestyle, especially in cities and towns, is being seen around the globe. Urbanization efforts by government bodies and higher income offered in urban locations can be cited as a major reason for the migration of people towards cities and towns. Job-related stress, especially in developing and developed countries, is a leading cause of depression. Furthermore, there is an increased chance of depression in individuals who have got a family history of depression, experienced childhood trauma, a less active frontal lobe in the brain and consumption of drugs, amongst others. In case of drug use, studies show that around 21% of individuals who have used banned substances (drugs) experience depression at some stage in their life, which in